Molecular BiologyCell ReportsPeer-reviewed
SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger…·Stefan Pöhlmann
258 citationstop 1%
Author
Anzhalika Sidarovich
German Primate CenterORCID 0000-0003-4367-207XUnclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2021-2021 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 45 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship2 papers
Recent·Most cited
- Molecular BiologybioRxivPreprint
Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination
Prerna Arora, Amy Madeleine Kempf, Inga Nehlmeier…·Markus Hoffmann
This study shows that the B.1.617.2 variant of SARS-CoV-2 evades antibodies from infection and vaccination, increases lung cell entry, and enhances cell fusion.
20 citations